Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Pharma
Boehringer Ingelheim preps for 2 upcoming oncology launches
The company expects to introduce brigimadlin in dedifferentiated liposarcoma and zongertinib in HER2-mutated non-small cell lung cancer next year.
Zoey Becker
Jun 10, 2024 8:20am
Boehringer Ingelheim plots 25 new launches over the next decade
Apr 16, 2024 4:30am
Pfizer eyes 8 blockbuster cancer drugs in new oncology plan
Feb 29, 2024 5:42pm
Biogen drops Aduhelm efforts after ill-fated accelerated approval
Jan 31, 2024 8:35am
Pfizer gears up for 'pivotal' 2023, CEO says
Oct 20, 2022 8:19am
Ionis to upgrade manufacturing ops with new site in California
Oct 12, 2022 11:07am
